Treatment of Intracerebral Lesions with Abatacept in a CTLA4-Haploinsufficient Patient
Top Cited Papers
- 1 May 2018
- journal article
- letter
- Published by Springer Science and Business Media LLC in Journal of Clinical Immunology
- Vol. 38 (4), 464-467
- https://doi.org/10.1007/s10875-018-0511-1
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Assessment of CTLA-4 Deficiency–Related Autoimmune Choroidopathy Response to AbataceptJAMA Ophthalmology, 2016
- Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4Journal of Allergy and Clinical Immunology, 2015
- Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutationsNature Medicine, 2014
- Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4Science, 2014
- Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4Immunity, 1995